TY - JOUR AU - Shien, Tadahiko PY - 2018 TI - The eligibility of primary tumor resection for de novo stage IV breast cancer patients JF - Translational Cancer Research; Vol 7, Supplement 5 (June 08, 2018): Translational Cancer Research Y2 - 2018 KW - N2 - There are many retrospective reports to indicate the survival benefit of primary tumor resection for de novo stage IV breast cancer. Moreover, several comprehensive reviews have described significant differences in survival time (hazard ratio of ~0.6) (1,2). However, retrospective reports include numerous biases. UR - https://tcr.amegroups.org/article/view/21832